AtriCure, Inc. (ATRC) Misses Q4 Loss Views by 2c/Share; Guides FY13 Revs
Tweet Send to a Friend
AtriCure, Inc. (NASDAQ: ATRC) reported Q4 EPS of ($0.12), $0.02 worse than the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
